Previous study showed that Guli capsule could suppress the adjuvant multiple arthritis; have inhibitory effect on carrageenan gelatinous and formaldehyde foot swelling; improve the symptom of osteoporosis patients; and improve pain and limited joint activities of rheumatoid patients. To further verify the clinical effect of Guli capsule in the treatment of knee osteoarthritis, the investigators perform this multi-center clinical study.
Guli capsule, an approved Chinese patent drug, its main indications are for rheumatism, rheumatoid arthritis. Previous study showed that Guli capsule could suppress the adjuvant multiple arthritis; have inhibitory effect on carrageenan gelatinous and formaldehyde foot swelling; improve the symptom of osteoporosis patients; and improve pain and limited joint activities of rheumatoid patients. To further verify the clinical effect of Guli capsule in the treatment of knee osteoarthritis, the investigators perform this multi-center clinical study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
220
Guli capsule,as the experimental drug,is taken 3 grains each time, 3 time per day
Kangguzengsheng capsule, as the active comparator, is taken 3 grains each time, 3 time per day
Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine
Beijing, Beijing Municipality, China
RECRUITINGOsteoarthritis index on the Western Ontario and McMaster Universities Osteoarthritis Index
Time frame: 4 weeks
Pain Scores on the Visual Analog Scale
Time frame: 4 weeks
Number of Participants with Adverse Events as a Measure of Safety
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.